Product image of Pantoprazolo Hikma (Pantoprazole) supplied by GNH India

Pantoprazolo Hikma

Active Ingredient:
Pantoprazole
Origin:
EU

Pantoprazolo Hikma (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazolo Hikma, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is indicated for conditions such as gastro‑oesophageal reflux disease, erosive oesophagitis and Zollinger‑Ellison syndrome in adult patients.

GNH India supplies Pantoprazolo Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring EU‑standard quality for global distribution.

Manufacturer / TM Owner

Hikma Farmacêutica (Portugal), S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Pantoprazolo Hikma, a proton pump inhibitor, is used to manage acid‑related gastrointestinal disorders.

  • Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by reducing gastric acid production.
  • Erosive oesophagitis: promotes healing of acid‑induced esophageal lesions.
  • Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.
  • NSAID‑induced ulcer prophylaxis: helps prevent gastric ulcers in patients receiving long‑term non‑steroidal anti‑inflammatory drugs.

How It Works

  • Pantoprazole selectively and irreversibly inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of gastric parietal cells. By blocking this final step of acid secretion, it markedly reduces both basal and stimulated gastric acid output, leading to an increased gastric pH.

Side Effects

Pantoprazolo Hikma may cause adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Headache
  • Diarrhea
  • Nausea
  • Abdominal pain
  • Flatulence
  • Constipation

Serious or Rare Side Effects

  • Severe allergic reaction (anaphylaxis)
  • Clostridioides difficile infection
  • Low magnesium (hypomagnesemia)
  • Elevated liver enzymes
  • Interstitial nephritis
  • Stevens‑Johnson syndrome

Precautions & Warnings

When prescribing Pantoprazolo Hikma, clinicians should consider several precautionary measures to ensure safe use.

  • Renal function assessment: adjust use in patients with severe renal impairment.
  • Magnesium monitoring: periodic checks are advised during long‑term therapy.
  • Hepatic impairment caution: use with care in patients with liver disease.
  • CYP2C19 interaction awareness: consider potential reduced efficacy with certain enzyme inhibitors.
  • Discontinuation strategy: avoid abrupt cessation after prolonged use to prevent rebound acid hypersecretion.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Pantoprazolo Hikma can affect the pharmacokinetics of several medicines; interactions are classified by clinical significance.

Major Interactions (Avoid)

  • Atazanavir and other HIV protease inhibitors: reduced absorption leading to loss of antiviral effect.
  • Clopidogrel: decreased activation, potentially reducing antiplatelet activity.
  • Methotrexate (high‑dose): increased serum levels, raising toxicity risk.
  • Digoxin: enhanced serum concentration, may require dose adjustment.
  • Warfarin (some reports): potential alteration of anticoagulant effect.

Moderate Interactions (Monitor Closely)

  • Omeprazole and other CYP2C19 inhibitors: may increase pantoprazole levels.
  • Rifampin and other CYP3A4 inducers: may decrease pantoprazole exposure.
  • Antifungal agents such as ketoconazole: possible increased plasma concentrations.
  • Antiretroviral efavirenz: may modestly reduce pantoprazole efficacy.
  • Diuretics (e.g., furosemide): risk of hypomagnesemia when combined long‑term.

Frequently Asked Questions

Pantoprazolo Hikma contains pantoprazole, a proton pump inhibitor indicated for the treatment of gastro‑oesophageal reflux disease (GERD), healing of erosive oesophagitis, and management of Zollinger‑Ellison syndrome, a condition characterized by excessive gastric acid production.

Pantoprazole acts by selectively and irreversibly inhibiting the H+/K+‑ATPase enzyme, also known as the gastric proton pump, on the secretory surface of parietal cells. This blockade prevents the final step of acid secretion, resulting in a sustained reduction of gastric acidity.

The appropriate dose of Pantoprazolo Hikma is determined by the prescribing healthcare professional based on the specific indication, patient characteristics, and clinical response. Dosage regimens may vary, and the prescriber will provide individualized instructions.

Pantoprazole is classified as a pregnancy category B medication in many regions, indicating no evidence of risk in animal studies and a lack of well‑controlled human studies. It should only be used during pregnancy or lactation if clearly needed and after a risk‑benefit assessment by the prescriber.

To order Pantoprazolo Hikma, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Pantoprazolo Hikma offers a pharmacokinetic profile with minimal CYP2C19 metabolism, reducing the likelihood of drug‑drug interactions compared with some other PPIs. Its efficacy in acid suppression is comparable to agents such as omeprazole and esomeprazole, while its safety and tolerability are consistent with the class.

Pantoprazolo Hikma should be stored at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Pantoprazolo Hikma is administered orally, typically as a tablet taken with water. It is usually taken once daily, preferably in the morning before a meal, unless the prescriber advises a different schedule based on the patient’s condition.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, hypomagnesemia with prolonged use, liver enzyme elevations, interstitial nephritis, and severe skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if these occur.

Pantoprazolo Hikma should be avoided in patients with known hypersensitivity to pantoprazole or other proton pump inhibitors. Caution is advised for individuals with severe hepatic impairment, those on medications that may interact significantly, and patients with a history of low magnesium levels or certain kidney disorders.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pantoprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT